These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 345121)

  • 1. Sounding board. Creative tension: FDA and medicine.
    Kennedy D
    N Engl J Med; 1978 Apr; 298(15):846-50. PubMed ID: 345121
    [No Abstract]   [Full Text] [Related]  

  • 2. Will PPIs affect your patients' attitudes?
    Patient Care; 1979 Feb; 13(3):190-1, 195-6. PubMed ID: 10240261
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA acts on estrogen, progestin labeling.
    FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006
    [No Abstract]   [Full Text] [Related]  

  • 4. Communicating with patients about their medications.
    Kessler DA
    N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the FDA packing a surprise for you?
    Chapman S
    Leg Aspects Med Pract; 1979 Nov; 7(11):35-8. PubMed ID: 263195
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA commissioner discusses issues of concern to hospital pharmacists. Interview by William A. Zellmer.
    Goyan JE
    Am J Hosp Pharm; 1980 May; 37(5):738-40 contd. PubMed ID: 7386484
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA puts forth proposal to mandate patient information.
    Wechsler J
    Formulary; 1995 Oct; 30(10):622-3. PubMed ID: 10151725
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiopharmaceuticals and FDA: a clinician's perspective.
    Siegel BA
    Med Instrum; 1981; 15(6):355-60. PubMed ID: 7040923
    [No Abstract]   [Full Text] [Related]  

  • 9. Current FDA directives for promoting public health.
    Hayes AH
    Am J Hosp Pharm; 1982 Mar; 39(3):427-31. PubMed ID: 7072727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA paves the way for drug law reform.
    Eichelberger BM
    Am J Hosp Pharm; 1978 Jul; 35(7):878, 882. PubMed ID: 665706
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA principles on clinical investigations.
    Anello C
    Psychopharmacol Bull; 1972 Apr; 8(2):31-5. PubMed ID: 4550366
    [No Abstract]   [Full Text] [Related]  

  • 12. Helpful tips for extralabel drug use: record keeping, record access, and product labels. The FDA-Center for Veterinary Medicine and the American Veterinary Medicine Association.
    J Am Vet Med Assoc; 1998 Mar; 212(5):666-7. PubMed ID: 9556375
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications for the FDA/Center for Veterinary Medicine (CVM).
    Geyer RE
    J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA cracks down on labeling, initiates trial result reporting.
    Osborne R; Waltz E
    Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug studies in children.
    Finkel MJ
    Pediatr Pharmacol (New York); 1980; 1(1):7-14. PubMed ID: 7346734
    [No Abstract]   [Full Text] [Related]  

  • 16. An interview with FDA commissioner Hayes.
    Small WE
    Am Pharm; 1981 Oct; NS21(10):27-36. PubMed ID: 6803557
    [No Abstract]   [Full Text] [Related]  

  • 17. A means to provide patient education: "Rx package inserts, patient package inserts, device labeling".
    Sherman M
    ONA J; 1979 Aug; 6(8):326-9. PubMed ID: 257297
    [No Abstract]   [Full Text] [Related]  

  • 18. Unapproved uses of approved drugs: The physician, the package insert, and the FDA.
    Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165
    [No Abstract]   [Full Text] [Related]  

  • 19. Scientific basis for nonapproved use of drugs in veterinary practice.
    Brumbaugh GW
    J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
    [No Abstract]   [Full Text] [Related]  

  • 20. Some effects of drug laws and regulations on the practice of medicine, with particular emphasis on inflammatory bowel disease.
    Goldstein F
    Am J Gastroenterol; 1988 Oct; 83(10):1091-7. PubMed ID: 3421219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.